Hepatic injury due to troglitazone.
Malik
A H
AH
Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas 75235-9151, USA.
Prasad
P
P
Saboorian
M H
MH
Thiele
D L
DL
Malet
P F
PF
D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology* / Q000473:pathology; D002839:Chromans / Q000009:adverse effects* / Q000627:therapeutic use; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D008099:Liver / Q000473:pathology; D008875:Middle Aged; D013844:Thiazoles / Q000009:adverse effects* / Q000627:therapeutic use; D045162:Thiazolidinediones; D000077288:Troglitazone
D002839:Chromans; D007004:Hypoglycemic Agents; D013844:Thiazoles; D045162:Thiazolidinediones; D000077288:Troglitazone